Why did the Air India Boeing 787 crash happen?
How will Trump's tariff threats impact the dollar?
What caused Oracle's stock to hit a record high?
Why was Sen. Alex Padilla forcibly removed at DHS press conference?
How will JetZero's factory affect North Carolina jobs?
Why is Google Cloud experiencing widespread outages?
How is Trump's blocking of California's EV mandate affecting the market?
FDA Expands AbbVie's Mavyret Label To Include Pediatric Patients With Hepatitis C Infection
benzinga.com/news/fda/25/06/45890526/fda-expands-abbvies-mavyret-label-to-include-pediatric-patients-with-hepatitis-c-infection
The U.S. Food and Drug Administration (FDA) approved a label expansion for AbbVie Inc’s (NYSE:ABBV) Mavyret (glecaprevir/pibrentasvir), an oral pangenotypic direct-acting antiviral (DAA) therapy.
It is now approved for adults and pediatric patients three years and older with acute or…
This story appeared on benzinga.com, 2025-06-11 17:46:36.